Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2010
12/15/2010CN101914099A Covalently linked oligonucleotide minor groove binder conjugates
12/15/2010CN101190934B Method for preparing Zidovudine azide intermediate by phase transition method
12/14/2010US7851617 Indole derivatives
12/14/2010US7851159 Method for detecting target nucleic acid with specific base sequence and set of nucleic acids for detection
12/14/2010US7851155 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
12/14/2010CA2307280C Analyte assay using particulate labels
12/09/2010US20100311961 Process and intermediates for the preparation of substituted 1,3-oxathiolanes, especially lamivudine
12/09/2010US20100311960 Phosphinoamidite Carboxylates and Analogs Thereof in the Synthesis of Oligonucleotide Having Reduced Internucleotide Charge
12/09/2010US20100311684 Novel tricyclic nucleosides or nucleotides as therapeutic agents
12/09/2010US20100311682 Antimelancholic medicine prepared with jujube camp materials
12/09/2010US20100311652 Genetic marker for use in the treatment of leukemia
12/09/2010US20100311178 Labelled nucleotides
12/08/2010EP2258711A2 New forms of 5-azacytidine
12/08/2010EP2258710A1 New polymorphic form of 5-azacytidine
12/08/2010EP2258709A1 2'-hydroxyl-protected ribonucleoside derivative and manufacturing method of same
12/08/2010EP2258376A1 Phosphonate analogs of HIV inhibitor compounds
12/08/2010EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
12/08/2010EP2257162A2 Crystal forms of 2-{2-ý(cyclohexyl)methylene¨hydrazino}adenosine
12/08/2010CN101906127A Method for extracting cordycepin and cordyceps polysaccharides from residue of cordyceps militaris culture medium
12/08/2010CN101906126A Method for separating purified cytidine diphosphate choline by hydrophobic chromatography
12/07/2010US7847092 Reacting fluorine salt containing radioactive fluorine-18 with alkyl halide or alkyl sulfonate in presence of alcohol; decreased reaction time; high yield; reduces the formation of side products
12/07/2010US7847075 2-Azapurine compounds and their use
12/07/2010CA2525498C Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
12/02/2010WO2010138855A1 Novel compounds and synthesis of tellurium-derivatized oligonucleotides for structural and functional studies
12/02/2010WO2010135918A1 Didanosine precursor drug and its preparation method
12/02/2010US20100305060 Nucleoside Prodrugs and Uses Thereof
12/02/2010US20100304381 Fluorescent nucleobase conjugates having anionic linkers
12/02/2010US20100304368 Components and method for enzymatic synthesis of nucleic acids
12/01/2010EP2256133A1 Bioconjugation of macromolecules
12/01/2010EP2256126A1 New labelling strategies for the sensitive detection of analytes
12/01/2010EP2254582A2 Methods of treating viral infections
12/01/2010EP1399176B1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
12/01/2010CN101903396A Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
12/01/2010CN101899080A Production method of golden-silk jujube cyclic adenosine monophosphate
12/01/2010CN101899079A Preparation, separation and purification method of Decitabine
11/2010
11/30/2010US7842517 rapid and sensitive detection of post-translationally modified proteins; exploits mutant of beta-1,4-galactosyltransferase to selectively transfer unnatural ketone functionality, for attaching biotin; detecting cancer, Alzheimer's disease, neurodegeneration, cardiovascular disease, and diabetes
11/30/2010CA2577339C Artificial rna modified at its 2' hydroxyl group
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/25/2010WO2010135569A1 N- [ (2 ' r) -2 ' -deoxy-2 ' -fluoro-2 ' -methyl-p-phenyl-5 ' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
11/25/2010WO2010135564A2 Novel compounds and derivatization of dnas and rnas on the nucleobases of pyrimidines for function, structure, and therapeutics
11/25/2010WO2010134992A2 Synthesis labile base protected - modified deoxy & modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis
11/25/2010WO2010134027A1 A chemo-enzymatic approach to the synthesis of pimecrolimus
11/25/2010WO2010081082A3 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
11/25/2010US20100298554 Compounds and methods for labeling oligonucleotides
11/25/2010US20100298550 Process for production of ribofuranose derivatives
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298257 Nucleoside phosphoramidates
11/25/2010US20100298256 Antiviral compounds
11/25/2010US20100298253 Pharmaceutical Compositions Comprising Forms of 5-Azacytidine
11/25/2010US20100297079 Compounds, compositions and methods for treating viral infection
11/25/2010CA2819700A1 N- [(2'r) -2'-deoxy-2'-fluoro-2' -methyl-p-phenyl-5' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
11/25/2010CA2763151A1 N- [(2'r) -2'-deoxy-2'-fluoro-2' -methyl-p-phenyl-5' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
11/25/2010CA2763034A1 A chemo-enzymatic approach to the synthesis of pimecrolimus
11/24/2010EP2253640A1 Photoresponsive nucleic acid manufacturing method
11/24/2010EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
11/24/2010EP2253621A1 A set of geldanamycin derivatives and their preparation methods
11/24/2010CN101896497A Antiviral agents
11/24/2010CN101891788A Preparation method of clolar and intermediate of clolar
11/24/2010CN101891787A Novel crystal form of gemcitabine hydrochloride and preparation method thereof
11/24/2010CN101891786A Ribavirin compound and new preparation method thereof
11/24/2010CN101891772A Method for preparing disodium 5'-ribonucleotide
11/24/2010CN101120947B Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
11/23/2010US7838643 Quaternary polymers
11/23/2010US7838508 such as 2-chloro-9-(4-thio-alpha-L-xylofuranosyl)adenine for treatment of leukemia; anticancer agents
11/23/2010US7838255 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/18/2010WO2010132513A1 2'-fluoro arabino nucleosides and use thereof
11/18/2010WO2010131475A1 NOVEL STABLE CRYSTAL OF 1-(2'-CYANO-2'-DEOXY-β-D-ARABINOFURANOSYL)CYTOSINE MONOHYDROCHLORIDE
11/18/2010WO2010130778A1 Method for the manufacture of 2-fluoro-ara-adenine
11/18/2010WO2010130726A1 Uracyl spirooxetane nucleosides
11/18/2010WO2010130233A1 Substituted 6-(benzylamino) purine riboside derivatives, use thereof and compositions containing these derivatives
11/18/2010US20100292458 Novel photolabile protective groups for improved processes to prepare oligonucleotide arrays
11/18/2010US20100292457 Dye-labeled ribonucleotide triphosphates
11/18/2010US20100292452 Modified nucleotides
11/18/2010US20100292180 Pharmaceutical Compositions Comprising Crystal Forms of 5-Azacytidine
11/18/2010US20100291547 Fluorogenic hydrazine-substituted compounds
11/18/2010US20100291031 Bicyclic nucleosides and nucleotides as therapeutic agents
11/18/2010US20100290990 Method for preparing a marked purine derivative, said derivative and uses thereof
11/18/2010CA2761880A1 2'-fluoro arabino nucleosides and use thereof
11/18/2010CA2760329A1 Uracyl spirooxetane nucleosides
11/17/2010EP2251015A1 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
11/17/2010EP1114827B1 Novel nucleic acid base pair
11/17/2010CN101525361B Prodrug based on gemcitabine structure as well as synthesizing method and application thereof
11/16/2010US7833988 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
11/16/2010US7833756 Methods of labelling polynucleotides with dibenzorhodamine dyes
11/16/2010CA2409613C Methods and compositions for treating hepatitis c virus
11/11/2010WO2010129666A1 Chemically programmable immunity
11/11/2010WO2010128156A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
11/11/2010WO2010127666A1 Method for the solid phase-based production of phosphate-bridged nucleoside conjugates
11/11/2010WO2010127443A1 Inhibitors of sialidase or sialidase-like enzymes
11/11/2010US20100286386 Combinatorial production of nucleotide and nucleoside (XiTP) analogues
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286084 Oligomer-Nucleoside Phosphate Conjugates
11/11/2010US20100286083 Nucleoside analogs
11/11/2010US20100286081 5-amino-3-(2',3'-di-o-acetyl-beta-d-ribofuranosyl)-3h-thiazolo[4,5-d] pyrimidin-2-oce salts and crystalline forms
11/11/2010DE102009020261A1 Verfahren zur festphasengestützten Herstellung phosphatverbrückter Nucleosid-Konjugate Method for solid-phase-based production phosphatverbrückter nucleoside conjugates
11/11/2010CA2760106A1 Inhibitors of sialidase or sialidase-like enzymes
11/10/2010CN1882333B Indole antiviral compositions
11/10/2010CN101883569A Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
11/10/2010CN101289455B Anti-influenza virus precursor drug and uses thereof
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 201